ArticleHaematologica2016

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.

Yoshihiro Inamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.